Vor Biopharma
Price & Volume
Stats
See moreOpen | $41.44 |
Previous Close | $39.89 |
Day Range | $41.44-$49.38 |
52W Range | $2.62-$65.80 |
Market Cap | $229.9M |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$273.60 |
News
See moreYahoo Finance • yesterday
Vor Bio Announces Late-Breaking Poster Presentation of Phase 3 Primary Sjögren’s Disease Clinical Study at ACR Convergence 2025
Yahoo Finance • 6 days ago
Vor Biopharma registers 51M shares for resale linked to RemeGen deal and PIPE financing
Yahoo Finance • 6 days ago
Vor Biopharma upgraded to Buy at Stifel on telitacicept prospects
Yahoo Finance • 12 days ago
Vor Biopharma trading halted on Thursday, news pending
About
CEO | Dr. Jean-Paul Kress M.D. |
CFO | Mr. Sandesh Mahatme L.L.M. |
Address | 100 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 154 |
